The Impact of Immunosuppressive Drugs on the Analysis of T-Cell Activation

E-ISSN： 1875-533x|7|7|673-692

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.7, Iss.7, 2000-07, pp. : 673-692

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging drugs for T-cell lymphoma

By Dickinson Michael Prince Henry Miles

Expert Opinion on Emerging Drugs, Vol. 19, Iss. 2, 2014-06 ,pp. : 201-213

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs in cutaneous T-cell lymphomas

By Dummer Reinhard

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 2, 2005-05 ,pp. : 381-392

Informa Healthcare

Access to resources Recommend Favorite

XII. Therapeutic exploitation of autologous T‐cell activation in B‐cell lymphoma

Hematological Oncology (Electronic), Vol. 33, Iss. S1, 2015-06 ,pp. : 67-69

John Wiley & Sons Inc

Access to resources Recommend Favorite

Modulation of Inducible Nitric Oxide Synthase Activation by Immuno-suppressive Drugs

Current Drug Metabolism, Vol. 2, Iss. 3, 2001-09 ,pp. : 315-329

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of oxatomide on T-cell activation and the production of interferon- in mite sensitive asthma

By Noma T. Yoshizawa I. Kawano Y. Nakajima T.

European Journal of Pharmacology, Vol. 343, Iss. 2, 1998-02 ,pp. : 239-247

Elsevier

Access to resources Recommend Favorite